| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | EVP, General Counsel | Common Stock | 509K | $4.03M | $7.92 | Mar 4, 2025 | Direct |
| Aurinia Pharmaceuticals Inc. | EVP, General Counsel | Employee Stock Option (right to buy) | 128K | Feb 28, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Feb 28, 2025 | 5 | -$975K | 4 | Mar 4, 2025 | EVP, General Counsel |
| AUPH | Aurinia Pharmaceuticals Inc. | Mar 6, 2024 | 1 | -$323K | 4 | Mar 7, 2024 | EVP, General Counsel |
| AUPH | Aurinia Pharmaceuticals Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 22, 2024 | EVP, General Counsel |
| AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 1 | -$172K | 4/A | Feb 22, 2024 | EVP, General Counsel |
| AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 2 | -$173K | 4 | Mar 6, 2023 | EVP, General Counsel |
| AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2022 | 3 | $0 | 4 | Mar 4, 2022 | EVP, General Counsel |